Advaxis, Inc.
Advaxis, Inc. (ADXS) Stock Competitors & Peer Comparison
See (ADXS) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADXS | $0.60 | +0.00% | 25.7M | -0.08 | -$7.99 | N/A |
| NONOF | $34.50 | -2.24% | 157.1B | 9.93 | $3.56 | +4.15% |
| CSLLY | $24.18 | -0.66% | 93B | 15.59 | $1.54 | +3.03% |
| UCBJY | $149.77 | +3.57% | 55.1B | 31.16 | $4.64 | +0.55% |
| UCBJF | $288.45 | -3.96% | 53.6B | 30.36 | $9.28 | +0.56% |
| ARGNF | $839.05 | +2.96% | 51.9B | 42.90 | $19.56 | N/A |
| CMXHF | $97.04 | +1.55% | 46.5B | 15.53 | $6.17 | +3.04% |
| WXIBF | $5.25 | +14.13% | 21.7B | 30.88 | $0.17 | N/A |
| IVBXF | $10.90 | +2.64% | 17.2B | 142.86 | $0.07 | N/A |
| WXXWY | $8.43 | +4.12% | 16.5B | 23.44 | $0.34 | N/A |
Stock Comparison
ADXS vs NONOF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NONOF has a market cap of 157.1B. Regarding current trading prices, ADXS is priced at $0.60, while NONOF trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NONOF's P/E ratio is 9.93. In terms of profitability, ADXS's ROE is +121.70%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ADXS is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NONOF's competition here
ADXS vs CSLLY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CSLLY has a market cap of 93B. Regarding current trading prices, ADXS is priced at $0.60, while CSLLY trades at $24.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CSLLY's P/E ratio is 15.59. In terms of profitability, ADXS's ROE is +121.70%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, ADXS is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CSLLY's competition here
ADXS vs UCBJY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, UCBJY has a market cap of 55.1B. Regarding current trading prices, ADXS is priced at $0.60, while UCBJY trades at $149.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas UCBJY's P/E ratio is 31.16. In terms of profitability, ADXS's ROE is +121.70%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, ADXS is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check UCBJY's competition here
ADXS vs UCBJF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, UCBJF has a market cap of 53.6B. Regarding current trading prices, ADXS is priced at $0.60, while UCBJF trades at $288.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas UCBJF's P/E ratio is 30.36. In terms of profitability, ADXS's ROE is +121.70%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, ADXS is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check UCBJF's competition here
ADXS vs ARGNF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ARGNF has a market cap of 51.9B. Regarding current trading prices, ADXS is priced at $0.60, while ARGNF trades at $839.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ARGNF's P/E ratio is 42.90. In terms of profitability, ADXS's ROE is +121.70%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, ADXS is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ARGNF's competition here
ADXS vs CMXHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CMXHF has a market cap of 46.5B. Regarding current trading prices, ADXS is priced at $0.60, while CMXHF trades at $97.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CMXHF's P/E ratio is 15.53. In terms of profitability, ADXS's ROE is +121.70%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, ADXS is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CMXHF's competition here
ADXS vs WXIBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, ADXS is priced at $0.60, while WXIBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas WXIBF's P/E ratio is 30.88. In terms of profitability, ADXS's ROE is +121.70%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, ADXS is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check WXIBF's competition here
ADXS vs IVBXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, IVBXF has a market cap of 17.2B. Regarding current trading prices, ADXS is priced at $0.60, while IVBXF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas IVBXF's P/E ratio is 142.86. In terms of profitability, ADXS's ROE is +121.70%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, ADXS is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check IVBXF's competition here
ADXS vs WXXWY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, WXXWY has a market cap of 16.5B. Regarding current trading prices, ADXS is priced at $0.60, while WXXWY trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas WXXWY's P/E ratio is 23.44. In terms of profitability, ADXS's ROE is +121.70%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, ADXS is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check WXXWY's competition here
ADXS vs GNMSF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GNMSF has a market cap of 16B. Regarding current trading prices, ADXS is priced at $0.60, while GNMSF trades at $267.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GNMSF's P/E ratio is 16.93. In terms of profitability, ADXS's ROE is +121.70%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, ADXS is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GNMSF's competition here
ADXS vs SBHMY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SBHMY has a market cap of 15.8B. Regarding current trading prices, ADXS is priced at $0.60, while SBHMY trades at $17.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SBHMY's P/E ratio is 46.45. In terms of profitability, ADXS's ROE is +121.70%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, ADXS is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SBHMY's competition here
ADXS vs SBMFF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, ADXS is priced at $0.60, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SBMFF's P/E ratio is 25.30. In terms of profitability, ADXS's ROE is +121.70%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, ADXS is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SBMFF's competition here
ADXS vs BRRGF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, ADXS is priced at $0.60, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, ADXS's ROE is +121.70%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, ADXS is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ADXS.Check BRRGF's competition here
ADXS vs AAVXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, ADXS is priced at $0.60, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, ADXS's ROE is +121.70%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, ADXS is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check AAVXF's competition here
ADXS vs TRSBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, TRSBF has a market cap of 8.4B. Regarding current trading prices, ADXS is priced at $0.60, while TRSBF trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas TRSBF's P/E ratio is 25.43. In terms of profitability, ADXS's ROE is +121.70%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, ADXS is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check TRSBF's competition here
ADXS vs ODTC Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, ADXS is priced at $0.60, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ODTC's P/E ratio is 1.07. In terms of profitability, ADXS's ROE is +121.70%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ADXS is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ODTC's competition here
ADXS vs AKBLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, ADXS is priced at $0.60, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas AKBLF's P/E ratio is 42.98. In terms of profitability, ADXS's ROE is +121.70%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, ADXS is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check AKBLF's competition here
ADXS vs REGMF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, ADXS is priced at $0.60, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas REGMF's P/E ratio is 51.63. In terms of profitability, ADXS's ROE is +121.70%, compared to REGMF's ROE of +0.33%. Regarding short-term risk, ADXS is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check REGMF's competition here
ADXS vs ABCZF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ADXS is priced at $0.60, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ADXS's ROE is +121.70%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, ADXS is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ABCZF's competition here
ADXS vs LABFF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ADXS is priced at $0.60, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ADXS's ROE is +121.70%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, ADXS is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check LABFF's competition here
ADXS vs SHJBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, ADXS is priced at $0.60, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, ADXS's ROE is +121.70%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, ADXS is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SHJBF's competition here
ADXS vs BRCTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, ADXS is priced at $0.60, while BRCTF trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BRCTF's P/E ratio is 30.89. In terms of profitability, ADXS's ROE is +121.70%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, ADXS is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BRCTF's competition here
ADXS vs CAMRF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, ADXS is priced at $0.60, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CAMRF's P/E ratio is 41.98. In terms of profitability, ADXS's ROE is +121.70%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, ADXS is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CAMRF's competition here
ADXS vs ZLDPF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ZLDPF has a market cap of 3.2B. Regarding current trading prices, ADXS is priced at $0.60, while ZLDPF trades at $44.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ZLDPF's P/E ratio is 3.20. In terms of profitability, ADXS's ROE is +121.70%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, ADXS is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ZLDPF's competition here
ADXS vs ASPHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ASPHF has a market cap of 3.1B. Regarding current trading prices, ADXS is priced at $0.60, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, ADXS's ROE is +121.70%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, ADXS is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ASPHF's competition here
ADXS vs GNNSF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, ADXS is priced at $0.60, while GNNSF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, ADXS's ROE is +121.70%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, ADXS is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GNNSF's competition here
ADXS vs INCPF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, ADXS is priced at $0.60, while INCPF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas INCPF's P/E ratio is 34.17. In terms of profitability, ADXS's ROE is +121.70%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, ADXS is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check INCPF's competition here
ADXS vs TLPPF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, TLPPF has a market cap of 2.9B. Regarding current trading prices, ADXS is priced at $0.60, while TLPPF trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas TLPPF's P/E ratio is -430.50. In terms of profitability, ADXS's ROE is +121.70%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, ADXS is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check TLPPF's competition here
ADXS vs MPSYF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ADXS is priced at $0.60, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ADXS's ROE is +121.70%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, ADXS is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check MPSYF's competition here
ADXS vs BVNKF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BVNKF has a market cap of 2.3B. Regarding current trading prices, ADXS is priced at $0.60, while BVNKF trades at $29.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BVNKF's P/E ratio is 10.92. In terms of profitability, ADXS's ROE is +121.70%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, ADXS is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BVNKF's competition here
ADXS vs GENSF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GENSF has a market cap of 2.3B. Regarding current trading prices, ADXS is priced at $0.60, while GENSF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GENSF's P/E ratio is 36.84. In terms of profitability, ADXS's ROE is +121.70%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, ADXS is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GENSF's competition here
ADXS vs BVNRY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, ADXS is priced at $0.60, while BVNRY trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BVNRY's P/E ratio is 10.74. In terms of profitability, ADXS's ROE is +121.70%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, ADXS is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BVNRY's competition here
ADXS vs GLPGF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, ADXS is priced at $0.60, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, ADXS's ROE is +121.70%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, ADXS is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GLPGF's competition here
ADXS vs HBMHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, HBMHF has a market cap of 2.1B. Regarding current trading prices, ADXS is priced at $0.60, while HBMHF trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas HBMHF's P/E ratio is 28.00. In terms of profitability, ADXS's ROE is +121.70%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, ADXS is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check HBMHF's competition here
ADXS vs MEOBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, ADXS is priced at $0.60, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, ADXS's ROE is +121.70%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, ADXS is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check MEOBF's competition here
ADXS vs ASCLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ASCLF has a market cap of 2B. Regarding current trading prices, ADXS is priced at $0.60, while ASCLF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ASCLF's P/E ratio is -47.50. In terms of profitability, ADXS's ROE is +121.70%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, ADXS is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ASCLF's competition here
ADXS vs BIESF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ADXS is priced at $0.60, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ADXS's ROE is +121.70%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, ADXS is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BIESF's competition here
ADXS vs PHMMF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, ADXS is priced at $0.60, while PHMMF trades at $96.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PHMMF's P/E ratio is 40.08. In terms of profitability, ADXS's ROE is +121.70%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, ADXS is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PHMMF's competition here
ADXS vs ONTTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ONTTF has a market cap of 1.4B. Regarding current trading prices, ADXS is priced at $0.60, while ONTTF trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ONTTF's P/E ratio is -7.35. In terms of profitability, ADXS's ROE is +121.70%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, ADXS is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ONTTF's competition here
ADXS vs SNBIF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, ADXS is priced at $0.60, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, ADXS's ROE is +121.70%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, ADXS is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SNBIF's competition here
ADXS vs CSPHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, ADXS is priced at $0.60, while CSPHF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CSPHF's P/E ratio is -21.25. In terms of profitability, ADXS's ROE is +121.70%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, ADXS is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CSPHF's competition here
ADXS vs MDCLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, ADXS is priced at $0.60, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, ADXS's ROE is +121.70%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, ADXS is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check MDCLF's competition here
ADXS vs PHGUF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, ADXS is priced at $0.60, while PHGUF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PHGUF's P/E ratio is -170.00. In terms of profitability, ADXS's ROE is +121.70%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, ADXS is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PHGUF's competition here
ADXS vs CSBTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, ADXS is priced at $0.60, while CSBTF trades at $28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CSBTF's P/E ratio is 355.00. In terms of profitability, ADXS's ROE is +121.70%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, ADXS is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CSBTF's competition here
ADXS vs PPTDF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, ADXS is priced at $0.60, while PPTDF trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PPTDF's P/E ratio is -46.11. In terms of profitability, ADXS's ROE is +121.70%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, ADXS is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PPTDF's competition here
ADXS vs NURPF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, ADXS is priced at $0.60, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NURPF's P/E ratio is 51.38. In terms of profitability, ADXS's ROE is +121.70%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, ADXS is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NURPF's competition here
ADXS vs IDRSF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, IDRSF has a market cap of 1B. Regarding current trading prices, ADXS is priced at $0.60, while IDRSF trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas IDRSF's P/E ratio is -6.20. In terms of profitability, ADXS's ROE is +121.70%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, ADXS is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check IDRSF's competition here
ADXS vs BTTAY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, ADXS is priced at $0.60, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ADXS's ROE is +121.70%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, ADXS is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BTTAY's competition here
ADXS vs TKBIF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, ADXS is priced at $0.60, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, ADXS's ROE is +121.70%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ADXS is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check TKBIF's competition here
ADXS vs BPMUF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, ADXS is priced at $0.60, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, ADXS's ROE is +121.70%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, ADXS is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BPMUF's competition here
ADXS vs IVEVF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, ADXS is priced at $0.60, while IVEVF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas IVEVF's P/E ratio is -1.24. In terms of profitability, ADXS's ROE is +121.70%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, ADXS is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check IVEVF's competition here
ADXS vs VBIZF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, VBIZF has a market cap of 622.3M. Regarding current trading prices, ADXS is priced at $0.60, while VBIZF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas VBIZF's P/E ratio is 29.50. In terms of profitability, ADXS's ROE is +121.70%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, ADXS is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check VBIZF's competition here
ADXS vs CKDXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, ADXS is priced at $0.60, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ADXS's ROE is +121.70%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, ADXS is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CKDXF's competition here
ADXS vs INRLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, INRLF has a market cap of 551.7M. Regarding current trading prices, ADXS is priced at $0.60, while INRLF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas INRLF's P/E ratio is -4.06. In terms of profitability, ADXS's ROE is +121.70%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, ADXS is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check INRLF's competition here
ADXS vs GNFTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GNFTF has a market cap of 544.4M. Regarding current trading prices, ADXS is priced at $0.60, while GNFTF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GNFTF's P/E ratio is -12.09. In terms of profitability, ADXS's ROE is +121.70%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, ADXS is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GNFTF's competition here
ADXS vs SOLTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SOLTF has a market cap of 504.1M. Regarding current trading prices, ADXS is priced at $0.60, while SOLTF trades at $5.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SOLTF's P/E ratio is -6.40. In terms of profitability, ADXS's ROE is +121.70%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, ADXS is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SOLTF's competition here
ADXS vs RAONF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ADXS is priced at $0.60, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ADXS's ROE is +121.70%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, ADXS is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check RAONF's competition here
ADXS vs GNFTY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, ADXS is priced at $0.60, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, ADXS's ROE is +121.70%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, ADXS is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check GNFTY's competition here
ADXS vs BOVNF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, ADXS is priced at $0.60, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, ADXS's ROE is +121.70%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, ADXS is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BOVNF's competition here
ADXS vs TBGNF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ADXS is priced at $0.60, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ADXS's ROE is +121.70%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, ADXS is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check TBGNF's competition here
ADXS vs CLVLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, ADXS is priced at $0.60, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, ADXS's ROE is +121.70%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, ADXS is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CLVLF's competition here
ADXS vs AVCTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, AVCTF has a market cap of 412.6M. Regarding current trading prices, ADXS is priced at $0.60, while AVCTF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas AVCTF's P/E ratio is -6.29. In terms of profitability, ADXS's ROE is +121.70%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, ADXS is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check AVCTF's competition here
ADXS vs PTCHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, ADXS is priced at $0.60, while PTCHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, ADXS's ROE is +121.70%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, ADXS is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PTCHF's competition here
ADXS vs CYDY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CYDY has a market cap of 330.7M. Regarding current trading prices, ADXS is priced at $0.60, while CYDY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CYDY's P/E ratio is -8.68. In terms of profitability, ADXS's ROE is +121.70%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, ADXS is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CYDY's competition here
ADXS vs CLVLY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CLVLY has a market cap of 328.8M. Regarding current trading prices, ADXS is priced at $0.60, while CLVLY trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CLVLY's P/E ratio is 14.56. In terms of profitability, ADXS's ROE is +121.70%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, ADXS is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CLVLY's competition here
ADXS vs NGENF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, ADXS is priced at $0.60, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NGENF's P/E ratio is -15.19. In terms of profitability, ADXS's ROE is +121.70%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, ADXS is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NGENF's competition here
ADXS vs HLOSF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, HLOSF has a market cap of 312.5M. Regarding current trading prices, ADXS is priced at $0.60, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas HLOSF's P/E ratio is -9.00. In terms of profitability, ADXS's ROE is +121.70%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, ADXS is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check HLOSF's competition here
ADXS vs NWBO Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NWBO has a market cap of 308.1M. Regarding current trading prices, ADXS is priced at $0.60, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NWBO's P/E ratio is -3.33. In terms of profitability, ADXS's ROE is +121.70%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, ADXS is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NWBO's competition here
ADXS vs FGHQF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, ADXS is priced at $0.60, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, ADXS's ROE is +121.70%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, ADXS is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check FGHQF's competition here
ADXS vs PBBIF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ADXS is priced at $0.60, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ADXS's ROE is +121.70%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ADXS is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PBBIF's competition here
ADXS vs SLNCF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, ADXS is priced at $0.60, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, ADXS's ROE is +121.70%, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, ADXS is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SLNCF's competition here
ADXS vs SPHDF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SPHDF has a market cap of 275.5M. Regarding current trading prices, ADXS is priced at $0.60, while SPHDF trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SPHDF's P/E ratio is -2.88. In terms of profitability, ADXS's ROE is +121.70%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, ADXS is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SPHDF's competition here
ADXS vs KNTPF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, KNTPF has a market cap of 265M. Regarding current trading prices, ADXS is priced at $0.60, while KNTPF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas KNTPF's P/E ratio is -9.42. In terms of profitability, ADXS's ROE is +121.70%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, ADXS is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check KNTPF's competition here
ADXS vs ORPOF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, ADXS is priced at $0.60, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, ADXS's ROE is +121.70%, compared to ORPOF's ROE of N/A. Regarding short-term risk, ADXS is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ORPOF's competition here
ADXS vs HNSBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, ADXS is priced at $0.60, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas HNSBF's P/E ratio is -4.14. In terms of profitability, ADXS's ROE is +121.70%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, ADXS is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check HNSBF's competition here
ADXS vs OPORF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, ADXS is priced at $0.60, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas OPORF's P/E ratio is 35.00. In terms of profitability, ADXS's ROE is +121.70%, compared to OPORF's ROE of +0.12%. Regarding short-term risk, ADXS is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check OPORF's competition here
ADXS vs NWPHF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NWPHF has a market cap of 239.6M. Regarding current trading prices, ADXS is priced at $0.60, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ADXS's ROE is +121.70%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, ADXS is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NWPHF's competition here
ADXS vs ORYZF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, ADXS is priced at $0.60, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, ADXS's ROE is +121.70%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, ADXS is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ORYZF's competition here
ADXS vs CMVLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, ADXS is priced at $0.60, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas CMVLF's P/E ratio is -9.33. In terms of profitability, ADXS's ROE is +121.70%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, ADXS is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check CMVLF's competition here
ADXS vs FPHAF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ADXS is priced at $0.60, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ADXS's ROE is +121.70%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, ADXS is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check FPHAF's competition here
ADXS vs MLLCF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, MLLCF has a market cap of 185.6M. Regarding current trading prices, ADXS is priced at $0.60, while MLLCF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas MLLCF's P/E ratio is -2.38. In terms of profitability, ADXS's ROE is +121.70%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, ADXS is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check MLLCF's competition here
ADXS vs RECEF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, ADXS is priced at $0.60, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas RECEF's P/E ratio is -8.33. In terms of profitability, ADXS's ROE is +121.70%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, ADXS is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check RECEF's competition here
ADXS vs ADOCY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ADXS is priced at $0.60, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ADXS's ROE is +121.70%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, ADXS is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ADOCY's competition here
ADXS vs BRIBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BRIBF has a market cap of 166.6M. Regarding current trading prices, ADXS is priced at $0.60, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BRIBF's P/E ratio is -5.78. In terms of profitability, ADXS's ROE is +121.70%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, ADXS is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BRIBF's competition here
ADXS vs SCNLF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SCNLF has a market cap of 151.1M. Regarding current trading prices, ADXS is priced at $0.60, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SCNLF's P/E ratio is -14.56. In terms of profitability, ADXS's ROE is +121.70%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, ADXS is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SCNLF's competition here
ADXS vs JWCTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, JWCTF has a market cap of 147.8M. Regarding current trading prices, ADXS is priced at $0.60, while JWCTF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas JWCTF's P/E ratio is -1.87. In terms of profitability, ADXS's ROE is +121.70%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, ADXS is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check JWCTF's competition here
ADXS vs AMGXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, ADXS is priced at $0.60, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ADXS's ROE is +121.70%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, ADXS is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check AMGXF's competition here
ADXS vs BBIXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, BBIXF has a market cap of 140.2M. Regarding current trading prices, ADXS is priced at $0.60, while BBIXF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas BBIXF's P/E ratio is -12.00. In terms of profitability, ADXS's ROE is +121.70%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, ADXS is more volatile compared to BBIXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check BBIXF's competition here
ADXS vs SPHRF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SPHRF has a market cap of 138.6M. Regarding current trading prices, ADXS is priced at $0.60, while SPHRF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SPHRF's P/E ratio is -33.00. In terms of profitability, ADXS's ROE is +121.70%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, ADXS is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SPHRF's competition here
ADXS vs NDTP Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, NDTP has a market cap of 136M. Regarding current trading prices, ADXS is priced at $0.60, while NDTP trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas NDTP's P/E ratio is -3.04. In terms of profitability, ADXS's ROE is +121.70%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, ADXS is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check NDTP's competition here
ADXS vs HBPCF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, ADXS is priced at $0.60, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, ADXS's ROE is +121.70%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, ADXS is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check HBPCF's competition here
ADXS vs TRGNF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, ADXS is priced at $0.60, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, ADXS's ROE is +121.70%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, ADXS is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check TRGNF's competition here
ADXS vs IPHYF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, ADXS is priced at $0.60, while IPHYF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas IPHYF's P/E ratio is -2.11. In terms of profitability, ADXS's ROE is +121.70%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, ADXS is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check IPHYF's competition here
ADXS vs AAPGV Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ADXS is priced at $0.60, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ADXS's ROE is +121.70%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, ADXS is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check AAPGV's competition here
ADXS vs SPHRY Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, SPHRY has a market cap of 126M. Regarding current trading prices, ADXS is priced at $0.60, while SPHRY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas SPHRY's P/E ratio is -60.00. In terms of profitability, ADXS's ROE is +121.70%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, ADXS is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check SPHRY's competition here
ADXS vs PSTTF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ADXS is priced at $0.60, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ADXS's ROE is +121.70%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ADXS is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check PSTTF's competition here
ADXS vs EPRXF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ADXS is priced at $0.60, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ADXS's ROE is +121.70%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, ADXS is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check EPRXF's competition here
ADXS vs POLBF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, POLBF has a market cap of 106.5M. Regarding current trading prices, ADXS is priced at $0.60, while POLBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas POLBF's P/E ratio is -7.55. In terms of profitability, ADXS's ROE is +121.70%, compared to POLBF's ROE of -0.54%. Regarding short-term risk, ADXS is more volatile compared to POLBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check POLBF's competition here
ADXS vs ADOIF Comparison April 2026
ADXS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXS stands at 25.7M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ADXS is priced at $0.60, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXS currently has a P/E ratio of -0.08, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ADXS's ROE is +121.70%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ADXS is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADXS.Check ADOIF's competition here